Background: Spectral EEG analysis using automated quantification of total absolute band power (tABP) for long-term brain monitoring is reliable. We hypothesised that tABP during the first critical days of life could be a useful tool for predicting later developmental outcomes. Objective: To determine whether measuring EEG background activity in premature infants with automated tABP quantification during the first 3 days of life correlated with their developmental outcomes at 24 months. Methods: Preterm infants (group 1, gestational age, GA 24–28 weeks and group 2, GA 28–31 weeks) were continuously monitored by EEG for 3 days after birth. Their developmental outcomes were assessed using the Bayley-II and Peabody-2 developmental tests at 24 months. Their respective indices were calculated. Normal (index ≥85) and abnormal (index <85) outcomes were correlated with the tABP. Results: In group 1, the tABP was significantly lower in the abnormal infants than in the normal infants. The specificity and negative predictive value were also high for all of the tests that were applied in this group. In group 2, there was no correlation between the tABP and developmental outcome. Conclusion: This study found that extremely premature infants with poor developmental outcomes had significantly lower tABP values in their first days of life compared to infants from the same group with normal outcomes. This method may be useful in predicting later outcomes in extremely premature infants and has the advantage of being automated.

Keywords:
Developmental outcome, EEG, Spectral EEG analysis, Brain monitoring, Premature
1.
Guevara RF, Giannuzzi R, Nosralla MO, Vignolo P, Moriette G, Maier MA: Positive slow waves in the EEG of premature infants between 24 and 36 weeks of conceptional age. Clin Neurophysiol 2008;119:180–189.
2.
Hayakawa M, Okumura A, Hayakawa F, Watanabe K, Ohshiro M, Kato Y, Takahashi R, Tauchi N: Background electroencephalographic (EEG) activities of very preterm infants born at less than 27 weeks gestation: a study on the degree of continuity. Arch Dis Child Fetal Neonatal Ed 2001;84:F163–F167.
3.
Vecchierini MF, Andre M, dʼAllest AM: Normal EEG of premature infants born between 24 and 30 weeks gestational age: terminology, definitions and maturation aspects. Neurophysiol Clin 2007;37:311–323.
4.
Connell J, de Vries L, Oozeer R, Regev R, Dubowitz LM, Dubowitz V: Predictive value of early continuous electroencephalogram monitoring in ventilated preterm infants with intraventricular hemorrhage. Pediatrics 1988;82:337–343.
5.
Hellstrom-Westas L, Rosen I: Electroencephalography and brain damage in preterm infants. Early Hum Dev 2005;81:255–261.
6.
Maruyama K, Okumura A, Hayakawa F, Kato T, Kuno K, Watanabe K: Prognostic value of EEG depression in preterm infants for later development of cerebral palsy. Neuropediatrics 2002;33:133–137.
7.
Okumura A, Kubota T, Toyota N, Kidokoro H, Maruyama K, Kato T, Hayakawa F, Watanabe K: Amplitude spectral analysis of maturational changes of delta waves in preterm infants. Brain Dev 2003;25:406–410.
8.
Okumura A, Kubota T, Tsuji T, Kato T, Hayakawa F, Watanabe K: Amplitude spectral analysis of theta/alpha/beta waves in preterm infants. Pediatr Neurol 2006;34:30–34.
9.
Victor S, Appleton RE, Beirne M, Marson AG, Weindling AM: Spectral analysis of electroencephalography in premature newborn infants: normal ranges. Pediatr Res 2005;57:336–341.
10.
Victor S, Appleton RE, Beirne M, Marson AG, Weindling AM: Effect of carbon dioxide on background cerebral electrical activity and fractional oxygen extraction in very low birth weight infants just after birth. Pediatr Res 2005;58:579–585.
11.
Victor S, Marson AG, Appleton RE, Beirne M, Weindling AM: Relationship between blood pressure, cerebral electrical activity, cerebral fractional oxygen extraction, and peripheral blood flow in very low birth weight newborn infants. Pediatr Res 2006;59:314–319.
12.
Schumacher EM, Westvik AS, Larsson PG, Lindemann R, Westvik J, Stiris TA: Feasibility of long-term continuous EEG monitoring during the first days of life in preterm infants: an automated quantification of the EEG activity. Pediatr Res 2011;69:413–417.
13.
Niemarkt HJ, Jennekens W, Pasman JW, Katgert T, VAN PC, Gavilanes AW, Kramer BW, Zimmermann LJ, Bambang OS, Andriessen P: Maturational changes in automated EEG spectral power analysis in preterm infants. Pediatr Res 2011;70:529–534.
14.
Glaria AP, Murray A: Comparison of EEG monitoring techniques: an evaluation during cardiac surgery. Electroencephalogr Clin Neurophysiol 1985;61:323–330.
15.
Klebermass K, Olischar M, Waldhoer T, Fuiko R, Pollak A, Weninger M: Amplitude-integrated EEG pattern predicts further outcome in preterm infants. Pediatr Res 2011;70:102–108.
16.
Bystron I, Blakemore C, Rakic P: Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci 2008;9:110–122.
17.
Volpe JJ: The encephalopathy of prematurity – brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol 2009;16:167–178.
18.
Allene C, Cattani A, Ackman JB, Bonifazi P, Aniksztejn L, Ben-Ari Y, Cossart R: Sequential generation of two distinct synapse-driven network patterns in developing neocortex. J Neurosci 2008;28:12851–12863.
19.
Wikstrom S, Lundin F, Ley D, Pupp IH, Fellman V, Rosen I, Hellstrom-Westas L: Carbon dioxide and glucose affect electrocortical background in extremely preterm infants. Pediatrics 2011;127:e1028–e1034.
20.
Granot S, Meledin I, Richardson J, Friger M, Shany E: Influence of respiratory acidosis and blood glucose on cerebral activity of premature infants. Pediatr Neurol 2012;47:19–24.
21.
Provost B, Heimerl S, McClain C, Kim NH, Lopez BR, Kodituwakku P: Concurrent validity of the Bayley Scales of Infant Development II Motor Scale and the Peabody Developmental Motor Scales-2 in children with developmental delays. Pediatr Phys Ther 2004;16:149–156.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.